Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.7 USD | -0.29% | +2.67% | +11.20% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.64% | 11.46B | B- | ||
-28.69% | 70.69B | B- | ||
+14.32% | 81.84B | C+ | ||
+9.37% | 29.03B | C+ | ||
-11.43% | 16.97B | B | ||
+0.32% | 16.83B | A- | ||
-0.24% | 15.28B | A- | ||
+6.24% | 12.41B | A- | ||
+33.40% | 12.26B | B- | ||
-31.40% | 11.83B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UHS Stock
- Ratings Universal Health Services, Inc.